Detalhe da pesquisa
1.
Burden-of-illness vaccine efficacy.
Pharm Stat
; 19(5): 636-645, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32220002
2.
Recombinant Zoster Vaccine Significantly Reduces the Impact on Quality of Life Caused by Herpes Zoster in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: A Randomized Placebo-Controlled Trial (ZOE-HSCT).
Biol Blood Marrow Transplant
; 25(12): 2474-2481, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31394276
3.
Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above.
BMC Infect Dis
; 18(1): 496, 2018 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30285731
4.
The temporal impact of aging on the burden of herpes zoster.
BMC Geriatr
; 17(1): 30, 2017 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28114907
5.
Correspondence regarding Wilson et al., cost-effectiveness of a comprehensive immunization program serving high-risk, uninsured adults.
Prev Med
; : 105973, 2020 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32122690
6.
Budget constraint and vaccine dosing: a mathematical modelling exercise.
Cost Eff Resour Alloc
; 12(1): 3, 2014 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24450591
7.
Differential Utility Losses in Herpes Zoster Cases Between Vaccinated and Unvaccinated Subjects: A Meta-analysis of Three Clinical Trials.
Clin Drug Investig
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662318
8.
The Impact of the COVID-19 Pandemic on the Incidence of Herpes Zoster: A Narrative Literature Review.
Infect Dis Ther
; 13(3): 447-461, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38441844
9.
Herpes zoster in older adults: Impact on carbon footprint in the United States.
Hum Vaccin Immunother
; 20(1): 2335722, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38698759
10.
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States.
Infect Dis Ther
; 13(4): 827-844, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38507143
11.
The respiratory syncytial virus prefusion F protein vaccine attenuates the severity of respiratory syncytial virus-associated disease in breakthrough infections in adults ≥60 years of age.
Influenza Other Respir Viruses
; 18(2): e13236, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38314063
12.
Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review.
Hum Vaccin Immunother
; 19(1): 2168952, 2023 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36916240
13.
Healthy ageing: Herpes zoster infection and the role of zoster vaccination.
NPJ Vaccines
; 8(1): 184, 2023 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38017011
14.
The potential impact of increased recombinant zoster vaccine coverage on the burden of herpes zoster among adults aged 50-59 years.
Vaccine
; 41(37): 5360-5367, 2023 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37541822
15.
Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies.
Hum Vaccin Immunother
; 19(3): 2278362, 2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37965770
16.
An Analysis of How Herpes Zoster Pain Affects Health-related Quality of Life of Placebo Patients From 3 Randomized Phase III Studies.
Clin J Pain
; 39(8): 386-393, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37166199
17.
Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer.
Hum Vaccin Immunother
; 19(1): 2167907, 2023 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36880669
18.
Lifetime risk of herpes zoster in the population of Beijing, China.
Public Health Pract (Oxf)
; 5: 100356, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36968763
19.
Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trials.
Pain
; 164(4): 741-748, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36066965
20.
Knowledge, Attitudes, and Practices of European Healthcare Professionals towards Hepatitis A and Hepatitis B Vaccination in at-Risk Adults.
Vaccines (Basel)
; 11(11)2023 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38005977